- Lobbying
- biotechnology AND research AND and AND development
Lobbying Arrangements Results for 'Biotechnology Research And Development'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Higher Education Related Research Appropriation Higher Education Policy and Student Aid Unmanned space exploration Biotechnology |
UNIVERSITY OF ARIZONA FOUNDATION
|
Strategic Impact, Inc. | |||
Details Supporting work related to COVID vaccine research, development, manufacturing, and procurement. Supporting work related to COVID vaccine research, development, manufacturing and procurement. |
Inovio Pharmaceuticals, Inc.
|
Cornerstone Government Affairs, Inc. | |||
Details Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and development of domestic advanced vaccine manufacturing platforms... |
iBio, Inc.
|
The Petrizzo Group, Inc. | |||
Details Prospective regulation of genome editing as targeted reproductive tool in agriculture Federal review and approval of biotech animals generally Care and treatment of biotech animals in research Anim... |
Recombinetics, Inc.
|
SLK Strategies | |||
Details The re-authorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill. |
Pfenex, Inc.
|
East End Group, LLC | |||
Details Provide strategic counsel and tactical planning to assist with development of clinical and regulatory programs for prophylactic and immunotherapeutic platform synthetic vaccine technologies. |
Generex Biotechnology Corporation
|
Barbour Griffith & Rogers, LLC d/b/a BGR Government Affairs | |||
Details Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Devel... |
Bavarian Nordic, Inc.
|
East End Group, LLC | |||
Details Biodefense Funding and oversight |
PHARMATHENE, INC
|
in-house lobbying | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF) - Strategic National Stockpile (SNS); Bi... |
Invivyd, Inc.
|
CGCN GROUP, LLC | |||
Details Lobbying related to Congressional and Administration introductions and company updates. |
WuXi Biologics USA LLC
|
FGS Global (US) LLC (FKA FGH Holdings LLC) | |||
Details Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and critical minerals. |
Ginkgo Bioworks, Inc.
|
Cornerstone Government Affairs, Inc. | |||
Details Monitor 2023 Farm Bill, Research, conservation and energy related programs Sustainable Aviation Fuel issues, generally Public Law 117-169, Inflation Reduction Act, Carbon capture including Section... |
LanzaTech Inc.
|
in-house lobbying | |||
Details Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage. Medicaid coverage issues. Legislative and regulatory issues affect... |
Biotechnology Industry Organization
|
Capitol Counsel LLC | |||
Details Oppose Independent Payment Advisory Board (IPAB). Medicare Part B Drug Reimbursement. Monitor Appropriations and Continuing Resolutions. Extend and expand Therapeutic Discovery Project (IRC 48D); c... |
Biotechnology Industry Organization
|
C2 GROUP, LLC | |||
Details Healthcare initiatives related to novel antibody technology platform; Issues related pandemic preparedness. Healthcare initiatives related to novel antibody technology platform. Issues related to p... |
Vir Biotechnology, Inc.
|
Forbes-Tate | |||
Details HCR -Issues related to healthcare legislation, drug pricing generally including and the 340B Drug Discount Program; issues and policies relating to the FDA including biopharmaceutical development a... |
Genentech
|
Rivendell Group LLP | |||
Details COVID-19 Vaccine research and development issues as follows: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency... |
RNAceuticals
|
Van Scoyoc Associates | |||
Details Budget Appropriations |
Green World Resources
waste coal treatment |
GSP Consulting Corp | |||
Details Upcoming "farm bill" re-authorization (of H.R. 2, the Agriculture Improvement Act) modernization for advanced biofuels, products and chemicals, especially regarding the energy title programs, inclu... |
BIO
|
Green Capitol LLC | |||
Details HR 6 "The 21st Century Cures Act," all provisions pertaining to patient access to treatments and orphan drug incentives. Senate draft legislation currently titled "Innovation for Healthier America... |
XOMA Corporation (FKA XOMA (US) LLC)
|
in-house lobbying | |||
Details Monitor H.R.3070/S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2012, Clinical studies for Autism. Monitor Public Law 112-74, Con... |
Curemark LLC
|
Van Scoyoc Associates | |||
Details H.R. 4394; S. 2443; Energy and Water Development Appropriations Bill, 2024; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy,... |
BATTELLE MEMORIAL INSTITUTE
|
in-house lobbying | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying | |||
Details Drug pricing issues |
GlaxoSmithKline
|
JST Strategies LLC (Jochum Shore & Trossevin PC) | |||
Details Farm Bill Commodity Programs Farm Bill Conservation Programs Support a Mandatory Base Acre Update Food and Agriculture Budget AFRI Funding Agriculture Appropriations Bill USDA part 340 regulations ... |
NATIONAL CORN GROWERS ASSN
|
in-house lobbying | |||
Details Educate and seek assistance from congressional offices and Administration officials on issues related to genetically engineered foods. Education and policy advocacy related to the creation and deve... |
Intrexon Corporation
|
SIDLEY AUSTIN LLP | |||
Details General education about policies impacting pharmaceutical development, approval, and reimbursement; H.R. 1628, American Health Care Act of 2017. Prescription drug user fee agreements and general e... |
Biogen Idec
|
Williams and Jensen, PLLC | |||
Details Policy to advance pharmaceutical research and development. 340B. Implementation of Inflation Reduction Act of 2022. |
Exelixis, Inc.
|
Todd Strategy Group | |||
Details Issues affecting biotechnology firms engaged in developing gene therapies, including: the MVP Act (H.R.2666) authorizing value based payments under the Medicaid program; Proposals to amend the drug... |
ReGenxBio
|
Knight Capitol Consultants | |||
Details Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369). |
Adaptive Biotechnologies
|
Arnold & Porter Kaye Scholer LLP | |||
Details Biotech Acceptance Roundup Ready Alfalfa Roundup Ready Sugarbeets HR 1260: Patent Reform Act of 2009 S. 515: Patent Reform Act of 2009 S. 610: Patent Reform Act of 2009 Environment Litigation- La... |
Monsanto Company
|
TROUTMAN SANDERS PUBLIC AFFAIRS GROUP, LLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process;... |
Vertex Pharmaceuticals Incorporated
|
in-house lobbying | |||
Details Bioterrorism Preparedness and development of medical countermeasures |
Genentech
Biotechnology |
Jochum Shore & Trossevin PC | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs provision in Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D drug rebates; ... |
Amgen, Inc.
|
Tiber Creek Group | |||
Details Michigan Farm Bureau continues to advocate for a long-term solution to our agricultural workforce needs. We continue to communicate to Congress on the out-of-control growth in the Adverse Effect Wa... |
Michigan Farm Bureau
|
in-house lobbying | |||
Details Issues related to Supplemental Nutrition Assistance Program (SNAP) purchasing restrictions, generally and with regard to the Agriculture Improvement Act of 2018, P.L. 115-334 Issues related to foo... |
PEPSICO, INC
|
in-house lobbying | |||
Details Monitor and engage on legislative and administrative action related to pollinator health and habitat promotion. Monitor and engage on legislative and administrative action related to Federal Insec... |
Bayer Corporation (consolidated report)
|
in-house lobbying | |||
Details Monitor implementation of P.L. 115-334, the Agriculture Act of 2018. Monitor progress of Livestock Mandatory Reporting Reauthorization. Monitor progress of S.949, "A bill to amend the Agricultura... |
National Pork Producers Council
|
in-house lobbying |